What is the connection between the Advanced Wound Care Innovation Symposium and EWMA?
Alira Health and EWMA have teamed up to feature the third annual Advanced Wound Care Innovation Symposium to highlight the early stage commercialization of the most innovative products in advance wound care.
Many have identified and described the gap between the invention, actual development, and eventual availability of therapies that help patients in everyday life. This, of course, is not unique to the field of wound care management, as the current rapid development of the discipline of translational medicine shows. Increasingly, institutions like NIH and the European Commission have set the tone by dedicating very large percentages of their health research budgets for translational medicine projects.
Both EWMA and Alira Health recognize this sub-optimal translation of basic science and early product development to clinically successful, available applications. Hence, they co-host the Advanced Wound Care Innovation Symposium at this year’s EWMA meeting in Krakow Poland on May 10th from 15:00 – 18:00.
This symposium will allow commercial ready advanced wound care technologies to present their new and innovative wound care initiatives to an audience of established C-Level executives, thought-leaders, and investors. Thus, this symposium aims to facilitate the closure of the bench-to-bedside gap, and ultimately boost the availability of new clinical therapies for patients with chronic and acute wounds.
Why should I register to attend the Advanced Wound Care Innovation Symposium?
The EWMA Advanced Wound Care Innovation Symposium allows you to hear about truly innovative companies in advanced wound care. On top of that, your visit opens-up the unique opportunity to network with the key executives within these companies, whether it’s to learn more about their new, innovative product, or to just shake hands and exchange contact details. In addition to the presentation of innovative wound healing ideas, the symposium program will also feature a panel discussion of the critical factor of Health Economics and Outcome Research (HEOR) in bringing new wound care therapies to market. Program attendees will get the chance to participate in a HEOR in Wound Care panel discussion, featuring some of the global leaders in the field. And of course, like previous years, there will be the famous networking session, where you can have a cocktail with the presenters, thought-leaders, entrepreneurs, clinical scientists, and executives of leading global wound care and pharmaceutical companies.
Is there a registration cost?
Best thing is that this all, innovation, networking, and HEOR, is available to you at no additional cost, other than your EWMA registration fee. We do ask you kindly to register your participation at https://alirahealthewma.com/ though, due to the limited capacity of the event.
Why would I want to send an application to present my innovations at the symposiums Innovation Session? And what is this about a 15,000 Euro prize?
The Alira Health & EWMA Advanced Wound Care Innovation Symposium currently has issued a Call for Innovation. In doing so, we are looking for true innovation, and we are searching the globe for wound care innovators, who would be willing to make a 10-15-minute presentation on their technology during the Innovation Session. So, if your product represents significant innovation to what is currently on the market, can enable wound care products or services, is IP protected, commercialized currently, or has a well-defined path to commercialization, please feel free to register on the Call for Innovation tab and sign-up to present. After all, this is a great opportunity for your start-up or early-stage company to present your new innovative wound care product or service to an audience of established wound care company executives, thought-leaders, and investors! And yes, the presentations that have been selected as finalists will subsequently be judged by the panel of wound care industry experts for the Wound Care Innovation Prize 2018 of 15,000 Euros.